2. Lower GI Bleed

Quick Recap

GI & Hepatology System, Protocol 2/13. Includes small bowel bleeding as a related, distinct entity.

1. Definition & Epidemiology

LGIB = bleeding distal to the ileocecal valve. Incidence 33-87/100,000, RISING relative to UGIB. Compared to UGIB: less hemodynamic compromise, lower transfusion requirement, lower 1-year mortality (4.2% vs 6-12% for UGIB) — generally a less acute entity, though individual cases can be severe. Typically self-limiting, but recurrence rate is HIGHER than UGIB (46% at 5 years). Patients who develop LGIB while hospitalized for another indication have markedly worse outcomes: ~23% in-hospital mortality — mirroring the same "in-hospital onset = worse prognosis" pattern seen in UGIB.

Advances in colonoscopic/radiologic therapy (hemoclips, superselective embolization) have reduced the need for emergent surgery.

2. Etiology

Diverticular bleeding is the most common cause — arterial, presents as painless episodes of bright red blood per rectum; spontaneously ceases in >80%, but ~25% develop recurrent bleeding.

No source is identified in a meaningful proportion of cases, partly dependent on colonoscopy timing.

3. Immediate Stabilization (ABCDE)

Same hemodynamic-based severity assessment as UGIB (resting hypotension = ~20-25% volume loss/massive bleeding; orthostatic change = 10-20% loss; neither = minor, <10% loss). Two large-bore IVs/central access, crystalloid resuscitation, PRBC-privileged transfusion strategy (same principles as UGIB — avoid reflexive component transfusion).

Risk factors for higher short-term morbidity (recurrent bleeding, hemodynamic compromise): syncope, aspirin/anticoagulant use, >2 comorbid conditions, continued bleeding 4 hours after presentation, PT >1.2x control, altered mental status.

Checklist:

4. ICU Triage Criteria

Admit to ICU: SBP <115 mmHg at presentation; moderate-severe bleeding onset while hospitalized for unrelated illness; ongoing instability despite resuscitation; inadequate Hct rise despite transfusion; low initial Hct (<25% with cardiopulmonary disease/stroke, <20% otherwise); PT >=1.2x control; MI/stroke/other systemic complication; unstable comorbidity/altered mental status; ongoing significant bleeding 4h after presentation; active oozing/spurting/visible vessel on endoscopy; requirement for angiography.

Regular floor: stable hemodynamics after resuscitation, mild Hct drop (<5%, baseline >30%), stable coagulation, no systemic complications, no ongoing bleeding at 4h.

Emergent UPPER endoscopy indicated (not colonoscopy) if: bright/dark red blood in stool WITH hemodynamic compromise, bloody NG aspirate, or suspicion of aortoenteric fistula (requires distal duodenal evaluation) — a critical branch point where the "lower GI bleed" presentation actually needs an upper workup first.

5. Colonoscopy — Timing and Technique

All patients with acute hematochezia eventually need FULL colonoscopy with terminal ileal intubation to establish a diagnosis. Exception: limited/significantly-improved LGIB with a high-quality colonoscopy showing diverticulosis within the prior 12 months may not need repeat colonoscopy.

No evidence supports urgent colonoscopy within 24 hours improving clinical outcomes — colonoscopy can be performed on a NONEMERGENT basis in stable patients, contrasting with UGIB's more time-pressured endoscopy windows (12h variceal/24h nonvariceal).

Unprepped colonoscopy or flexible sigmoidoscopy is NOT recommended except in specific likely-distal-colonic-source scenarios — adequate bowel prep matters for diagnostic yield and safety.

6. When Colonoscopy Is Precluded — Alternative Localization

When rapid bleeding, hemodynamic instability, impaired coagulation, comorbidities, or inability to tolerate bowel prep preclude early colonoscopy:

• CT angiography (CTA): fast, convenient bleeding localization
• Tagged RBC scan: can detect bleeding rates as low as 0.1-0.5 mL/min in research settings, though only ~45% of tagged RBC scans show extravasation clinically. Rapidly positive scans have the highest accuracy and best predict successful subsequent angiographic localization; delayed positive scans have much lower localization sensitivity (intestinal peristalsis moves the tagged blood, confounding the reading) — timing of positivity matters as much as positivity itself.
• Selective angiography: the final option short of surgery for patients with positive localizing imaging or those too unstable for other studies. If a rapidly bleeding site is found: vasopressin infusion after selective catheterization (induces vasoconstriction/cessation) OR embolization of the bleeding vessel. Angiography complications: dye-related (renal failure/contrast nephropathy), procedure-related (hematoma, retroperitoneal bleeding, intestinal ischemia), vasopressin-related (arrhythmia, MI).

7. Diagnostic Certainty Framework

A genuine clinical dilemma: is the lesion FOUND actually the SOURCE of bleeding? Active bleeding/stigmata are not always identifiable on the true culprit lesion, and multiple potential lesions may coexist.

This framework should explicitly inform whether surgery is appropriate based on diagnostic test results — do not proceed to surgical resection on equivocal-level evidence alone.

8. Small Bowel Bleeding (Related, Distinct Entity)

Accounts for 5-10% of GIB presentations, formerly termed "obscure GIB" — persistent/recurrent bleeding with no source found on conventional upper/lower endoscopy. Angiodysplasia is the most common mechanism overall; etiology varies by age. Other causes: tumors (cancers, stromal tumors, lymphoma), NSAID-induced small bowel injury, radiation enteropathy, Meckel diverticulum, Crohn's disease, aortoenteric fistula, varices, Dieulafoy lesion.

Diagnostic approach (stability-dependent):

• Rapid/severe bleeding + hemodynamic compromise: immediate selective angiography + embolization
• Rapid but stabilizable: CTA or tagged RBC scan
• Not rapid/stable, or initial imaging negative: upper + lower endoscopy (consider second-look upper endoscopy for recurrent melena); push enteroscopy as initial upper endoscopy choice if small bowel bleeding suspected at presentation
• After nondiagnostic upper/lower endoscopy: video capsule endoscopy (VCE) — diagnostic yield 38-83%, the test of choice for STABLE patients with suspected small bowel bleeding. Limitations: no real-time interpretation, localization is nearly impossible, no therapeutic capability, false-negative/false-positive results occur.
• CT/MR enterography if bowel obstruction suspected or capsule endoscopy negative (assesses luminal/mural lesions)
• Deep enteroscopy (balloon-assisted or spiral): reaches nearly the entire small bowel, CAN provide therapy, but higher morbidity than routine endoscopy; typically VCE-directed, but can be first-line with high suspicion, altered anatomy, or VCE contraindication; retrograde balloon enteroscopy for suspected ileal bleeding
• Hemodynamically UNSTABLE patients with suspected small bowel bleeding: go straight to radiologic evaluation (CTA/angiography), NOT VCE — VCE is a stable-patient tool only
• Intraoperative enteroscopy: reserved for healthy patients with recurrent significant bleeding and a likely small bowel source, failed repeated endoscopic attempts, or localization for planned surgical resection
• Provocative measures (heparin/thrombolytic/vasodilator administration to unmask a bleeding source): very rarely used, should generally NOT be recommended except in highly refractory situations, patients without comorbidities, under close experienced observation

9. Organ Support

Blood product resuscitation (PRBC-privileged, restrictive strategy per UGIB protocol principles); standard ICU supportive care; nutrition once bleeding controlled.

10. Consultation Matrix

11. Monitoring Framework

Serial Hct, hemodynamic monitoring, watch for the "4-hour ongoing bleeding" threshold as an active escalation trigger, post-embolization monitoring for bowel ischemia.

12. Complications

Recurrent bleeding (46% at 5 years — higher than UGIB), colonic ischemia (post-embolization or diverticular-ischemic overlap), angiography complications (Section 6), missed aortoenteric fistula, capsule endoscopy retention (rare, in strictures/obstruction). Prevention: appropriate colonoscopy timing (non-emergent when stable), diagnostic certainty framework before committing to surgery, unstable-patient triage directly to radiologic localization rather than VCE. Rescue: repeat colonoscopy/angiography, embolization, surgery for refractory/recurrent bleeding.

13. Escalation & De-escalation

Escalate: ongoing bleeding at 4h, hemodynamic instability -> CTA/tagged scan/angiography per Section 6, ICU admission.

De-escalate: bleeding spontaneously ceased (as occurs in >80% of diverticular bleeding), stable Hct, no ongoing bleeding at 4h -> non-emergent colonoscopy, floor-level care.

14. ICU Discharge Criteria

Hemodynamically stable, no ongoing bleeding, source identified (or diagnostic certainty framework applied to guide follow-up if not), colonoscopy completed or non-emergent plan in place, recurrence risk counseling given (46% at 5 years).

15. Documentation & Medicolegal Checklist

16. Key Guidelines

Sengupta N, Feuerstein JD, Jairath V, et al. Management of patients with acute lower gastrointestinal bleeding: updated ACG guideline. Am J Gastroenterol. 2023;118(2):208-231. Gerson LB, Fidler JL, Cave DR, et al. ACG clinical guideline: diagnosis and management of small bowel bleeding. Am J Gastroenterol. 2015;110(9):1265-1287.

17. Controversies

Optimal timing for colonoscopy in LGIB remains debated in practice despite guideline movement away from mandatory urgency — no RCT evidence supports a 24h window improving outcomes, yet many institutions still pursue early colonoscopy reflexively. The diagnostic certainty framework (Section 7) is a genuinely useful but under-utilized tool — practice variation exists in how rigorously it's applied before surgical referral. VCE's lack of real-time interpretation and localization difficulty remains a practical limitation without a fully satisfactory alternative for stable small bowel bleeding evaluation.

18. References

1. Amornsawadwattana S, Gyawali CP. Gastrointestinal Bleeding. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 52).
2. Sengupta N, Feuerstein JD, Jairath V, et al. Management of patients with acute lower gastrointestinal bleeding: updated ACG guideline. Am J Gastroenterol. 2023;118(2):208-231.
3. Gerson LB, Fidler JL, Cave DR, et al. ACG clinical guideline: diagnosis and management of small bowel bleeding. Am J Gastroenterol. 2015;110(9):1265-1287.
4. ASGE Standards of Practice Committee, Gurudu SR, Bruining DH, et al. The role of endoscopy in the management of suspected small-bowel bleeding. Gastrointest Endosc. 2017;85(1):22-31.

See also: Upper GI Bleed (GI & Hepatology System) for the shared resuscitation principles, anticoagulation management, and the important "hematochezia may have an upper source" caveat.